- Founded
- 2010
- Business Model
- B2B
- Website
- amoeba-nature.com
About
Amoéba is an innovative company created in July 2010 by Fabrice Plasson to develop a University of Lyon patent based on the amoeba Willaertia magna C2c Maky, a single-celled organism isolated from a natural environment that can fight legionella proliferation. The company later diversified into two technologies: living amoeba used to treat water, surfaces, and chronic wounds, and a lysed amoeba form used as agricultural biocontrol against phytopathogenic microorganisms. Listed on Euronext Paris since July 2015 after raising capital, Amoéba develops scientific, industrial, and commercial expertise around natural alternatives to chemical treatments for water, wounds, and plant protection.
Tech & App Stack
1 technology or app tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/amoeba"><img src="https://indexed.vc/api/badge/company/amoeba" alt="AMOEBA on Indexed.vc" width="260" height="76" /></a>